Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.37 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.37 |
| ▸ | FABP3 | P05413 | 2/20 | 0.36 |
| ▸ | FABP4 | P15090 | 2/20 | 0.36 |
| ▸ | FABP5 | Q01469 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8884997 | 0.82 | GABRA1 (0.46) | GABRA1GABRB2FABP3FABP4FABP5 | |
| SCHEMBL24344711 | 0.81 | CYP1A2 (0.38) | CYP1A2CYP2D6 | |
| SCHEMBL1087552 | 0.73 | GABRA1 (0.59) | CYP1A2CYP2D6GABRA1GABRB2FABP3 | |
| SCHEMBL31502507 | 0.71 | GABRA1 (0.48) | GABRA1GABRB2FABP3FABP4FABP5 | |
| SCHEMBL915884 | 0.71 | GABRA1 (0.48) | GABRA1GABRB2FABP3FABP4FABP5 | |
| SCHEMBL24344597 | 0.70 | CYP1A2 (0.38) | CYP1A2CYP2D6GABRA1GABRB2FABP3 | |
| SCHEMBL19619459 | 0.69 | GABRA1 (0.46) | CYP1A2CYP2D6GABRA1GABRB2FABP3 | |
| SCHEMBL809764 | 0.68 | CYP1A2 (0.54) | CYP1A2CYP2D6GABRA1GABRB2FABP3 | |
| SCHEMBL10891788 | 0.68 | ALOX15 (0.39) | CYP1A2CYP2D6GABRA1GABRB2 | |
| SCHEMBL23172717 | 0.67 | CYP1A2 (0.44) | CYP1A2CYP2D6GABRA1GABRB2FABP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220085302-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2022-03-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220085302-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | LIFR, LBR, EPOR | CYP1A2 1500/4885CYP2D6 1945/4885GABRA1 460/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.